Kyekyoon Kevin Kim
Overview
Explore the profile of Kyekyoon Kevin Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jin Y, Kim S, Cheng F, Shin J, Park J, Lee S, et al.
Biomaterials
. 2010 Nov;
32(3):899-908.
PMID: 21035846
High mobility group box 1 (HMGB1) is a family of endogenous molecules that is released by necrotic cells and causes neuronal damages by triggering inflammatory processes. In the cerebral ischemic...
12.
Cheng F, Choy Y, Choi H, Kim K
Int J Pharm
. 2010 Oct;
403(1-2):90-5.
PMID: 20971173
A diffusion-based model describing the drug release from a charged hydrogel (gelatin) microsphere undergoing enzymatic degradation is presented. The model elucidates the effect of glutaraldehyde, a crosslinking agent, on the...
13.
Choy Y, Cheng F, Choi H, Kim K
Macromol Biosci
. 2008 Aug;
8(12):1173-81.
PMID: 18702170
Uniform chitosan microspheres have been fabricated and weakly crosslinked for potential applications in colon-specific drug delivery. The effects of microsphere size, crosslinking density and electrostatic interactions between the drug and...
14.
Choy Y, Cheng F, Choi H, Kim K
Macromol Biosci
. 2008 May;
8(8):758-65.
PMID: 18446808
Uniform gelatin microspheres (GMS) of a wet size of 100 microm in diameter were fabricated by the electric field assisted precision particle fabrication (E-PPF) method and crosslinked with different glutaraldehyde...
15.
Berkland C, Pollauf E, Raman C, Silverman R, Kim K, Pack D
J Pharm Sci
. 2007 Apr;
96(5):1176-91.
PMID: 17455338
Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule delivery requires invasive methods such as frequently repeated...
16.
Choy Y, Choi H, Kim K
Macromol Biosci
. 2007 Apr;
7(4):423-8.
PMID: 17429828
Uniform biodegradable hydrogel microspheres (HMS) with precisely controlled size have been fabricated using an electric-field-assisted precision particle fabrication technique. Particle agglomeration was prevented by charging the hydrogel drops and allowing...
17.
Berkland C, Pollauf E, Varde N, Pack D, Kim K
Pharm Res
. 2007 Mar;
24(5):1007-13.
PMID: 17372691
Purpose: Encapsulation of liquids into biodegradable polymer microcapsules has been a challenging task due to production limitations stemming from solution viscosity, phase stabilization, molecular localization, and scalable production. We report...
18.
Pollauf E, Kim K, Pack D
J Pharm Sci
. 2005 Jul;
94(9):2013-22.
PMID: 16052542
Addition of biodegradable polymer shells surrounding polymeric, drug-loaded microparticles offers the opportunity to control drug release rates. A novel fabrication method was used to produce microparticles with precise control of...
19.
Pollauf E, Berkland C, Kim K, Pack D
Int J Pharm
. 2005 Jul;
301(1-2):294-303.
PMID: 16051452
Double-wall microspheres (DWMS), comprising distinct polymer core and shell phases, are useful and interesting for controlled-release drug delivery. In particular, the presence of a surface-eroding polymer core may be expected...
20.
Berkland C, Pack D, Kim K
Biomaterials
. 2004 May;
25(25):5649-58.
PMID: 15159081
Improved control of surface micro- and nano-structure may lead to enhanced performance of degradable biomedical devices such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided...